ME01952B - 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones - Google Patents

2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones

Info

Publication number
ME01952B
ME01952B MEP-2011-334A MEP33411A ME01952B ME 01952 B ME01952 B ME 01952B ME P33411 A MEP33411 A ME P33411A ME 01952 B ME01952 B ME 01952B
Authority
ME
Montenegro
Prior art keywords
pyrido
pyrimidin
dihydro
ones
amino
Prior art date
Application number
MEP-2011-334A
Other languages
English (en)
French (fr)
Inventor
X Michael Wang
Kris Mendenhall
Yasheen Zhou
Baoqing Gong
Dan Gu
John Dolan
John Tulinsky
Kristin Brinner
Zhenhai Gao
Daniel Poon
Timothy D Machajewski
Paul A Barsanti
Xiaodong Lin
Abran Costales
Alice Rico
Nathan Brammeier
Teresa Pick
Paul A Renhowe
Cynthia M Shafer
Christopher Mcbride
William Antonios-Mccrea
Brandon M Doughan
Barry H Levine
Yi Xia
Maureen Mckenna
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ME01952B publication Critical patent/ME01952B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
MEP-2011-334A 2005-09-30 2006-09-28 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones ME01952B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72279605P 2005-09-30 2005-09-30
US83688606P 2006-08-09 2006-08-09
EP06825272A EP1928875B1 (en) 2005-09-30 2006-09-28 2-amino-7,8-dihydro-6H-pyrido(4,3-d)pyrimidin-5-ones, process for their preparation and pharmaceutical compositions containing the same
PCT/US2006/038181 WO2007041362A1 (en) 2005-09-30 2006-09-28 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones

Publications (1)

Publication Number Publication Date
ME01952B true ME01952B (en) 2011-12-31

Family

ID=37661234

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2011-334A ME01952B (en) 2005-09-30 2006-09-28 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones

Country Status (32)

Country Link
US (2) US7671059B2 (me)
EP (1) EP1928875B1 (me)
JP (2) JP5036002B2 (me)
KR (1) KR101311757B1 (me)
AR (1) AR058072A1 (me)
AT (1) ATE514694T1 (me)
AU (1) AU2006297124B2 (me)
BR (1) BRPI0616701A2 (me)
CA (1) CA2624253C (me)
CR (1) CR9846A (me)
CY (1) CY1112028T1 (me)
DK (1) DK1928875T3 (me)
EA (1) EA016152B1 (me)
EC (1) ECSP088324A (me)
GE (1) GEP20115231B (me)
HK (1) HK1118823A1 (me)
HR (1) HRP20110655T1 (me)
IL (1) IL190446A0 (me)
JO (1) JO2783B1 (me)
MA (1) MA29885B1 (me)
ME (1) ME01952B (me)
MY (1) MY143604A (me)
NO (1) NO342258B1 (me)
NZ (1) NZ566914A (me)
PE (1) PE20070621A1 (me)
PL (1) PL1928875T3 (me)
PT (1) PT1928875E (me)
RS (1) RS51795B (me)
SM (1) SMAP200800029A (me)
TN (1) TNSN08143A1 (me)
TW (1) TWI373471B (me)
WO (1) WO2007041362A1 (me)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN101225083A (zh) * 2007-01-16 2008-07-23 北京摩力克科技有限公司 四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
US20110053873A1 (en) * 2008-02-01 2011-03-03 Takeda Pharmaceutical Company Limited Hsp90 inhibitors
CA2737948A1 (en) * 2008-09-26 2010-04-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Host cell kinases as targets for antiviral therapies against hcv infection
EP2370079A2 (en) * 2008-11-28 2011-10-05 Novartis AG Hsp90 inhibitors for therapeutic treatment
CA2742743C (en) * 2008-11-28 2017-05-23 Novartis Ag Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor
MX2011005667A (es) * 2008-11-28 2011-06-16 Novartis Ag Combinacion farmaceutica que comprende un inhibidor de hsp90 y un inhibidor de mtor.
AR075180A1 (es) * 2009-01-29 2011-03-16 Novartis Ag Formulaciones orales solidas de una pirido-pirimidinona
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
MY173494A (en) * 2009-10-29 2020-01-29 Genosco Kinase inhibitors
WO2012104823A2 (en) 2011-02-04 2012-08-09 Novartis Ag Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
RU2017119219A (ru) 2011-10-14 2018-11-02 Новартис Аг 2-карбоксамид циклоамино производные мочевины в комбинации с ингибиторами hsp90 для лечения пролиферативных заболеваний
ITTO20111013A1 (it) 2011-11-03 2013-05-04 Dac Srl Composti farmaceutici
CN103664938A (zh) * 2012-09-12 2014-03-26 山东亨利医药科技有限责任公司 含有嘧啶并环的syk抑制剂
KR20150081344A (ko) 2012-11-07 2015-07-13 노파르티스 아게 조합 요법
US9677907B2 (en) * 2013-03-14 2017-06-13 Itron Inc Intelligent receptacle
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds
EP3053578B1 (en) 2013-09-30 2020-12-23 Taiho Pharmaceutical Co., Ltd. Combination cancer therapy using azabicyclo compound
EP3189051A1 (en) * 2014-09-02 2017-07-12 Pierre Fabre Medicament Isoquinolinone derivatives useful in the treatment of cancer
KR20160035411A (ko) * 2014-09-23 2016-03-31 주식회사 오스코텍 LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물
KR101653560B1 (ko) * 2016-02-02 2016-09-12 한국화학연구원 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
RU2629599C1 (ru) * 2016-09-28 2017-08-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ химиолучевого лечения опухолей прямой кишки и анального канала
US20230295108A1 (en) * 2020-06-26 2023-09-21 Nihon Nohyaku Co., Ltd. Aryltetrahydropyridine derivative or salt thereof, insecticidal agent containing the compound, and method of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165873A (ja) 1984-09-07 1986-04-04 Mitsui Petrochem Ind Ltd ２−ピペラジノピリミジン誘導体
CA1307786C (en) 1984-12-14 1992-09-22 Keiichi Yokoyama Quinazoline derivatives and antihypertensive preparations containing same as effective components
IL85347A0 (en) * 1987-02-11 1988-07-31 May & Baker Ltd Cyclic diones
WO2002064594A2 (en) * 2001-02-12 2002-08-22 F. Hoffmann-La Roche Ag 6-substituted pyrido-pyrimidines
DE102004018198A1 (de) * 2004-04-15 2005-11-03 Merck Patent Gmbh Sulfonamide
WO2006045010A2 (en) 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
US20100152206A1 (en) 2005-01-07 2010-06-17 Ralph Mazitschek Bicyclic Dihydropyrimidines and Uses Thereof
KR20080006614A (ko) 2005-04-14 2008-01-16 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 증식 질환의 치료에 유용한 ｈｓｐ90 억제제인2-아미노-퀴나졸린-5-온

Also Published As

Publication number Publication date
CR9846A (es) 2008-08-01
JP2009510108A (ja) 2009-03-12
HK1118823A1 (me) 2009-02-20
TW200728304A (en) 2007-08-01
US7671059B2 (en) 2010-03-02
CY1112028T1 (el) 2015-11-04
HRP20110655T1 (hr) 2011-10-31
PL1928875T3 (pl) 2011-11-30
AR058072A1 (es) 2008-01-23
NO20082069L (no) 2008-06-09
KR20080057318A (ko) 2008-06-24
MA29885B1 (fr) 2008-10-03
CA2624253A1 (en) 2007-04-12
NZ566914A (en) 2011-09-30
SMP200800029B (it) 2008-05-07
MY143604A (en) 2011-06-15
PT1928875E (pt) 2011-09-06
RS51795B (en) 2011-12-31
JP2012158611A (ja) 2012-08-23
JO2783B1 (en) 2014-03-15
WO2007041362A1 (en) 2007-04-12
BRPI0616701A2 (pt) 2011-06-28
EA016152B1 (ru) 2012-02-28
GEP20115231B (en) 2011-06-10
DK1928875T3 (da) 2011-10-03
EP1928875B1 (en) 2011-06-29
US20070123546A1 (en) 2007-05-31
SMAP200800029A (it) 2008-05-07
CA2624253C (en) 2015-06-16
TNSN08143A1 (en) 2009-07-14
IL190446A0 (en) 2008-11-03
KR101311757B1 (ko) 2013-09-26
EP1928875A1 (en) 2008-06-11
ECSP088324A (es) 2008-04-28
NO342258B1 (no) 2018-04-30
JP5036002B2 (ja) 2012-09-26
EA200800992A1 (ru) 2008-10-30
US20100004237A1 (en) 2010-01-07
PE20070621A1 (es) 2007-09-06
AU2006297124A1 (en) 2007-04-12
TWI373471B (en) 2012-10-01
AU2006297124B2 (en) 2011-12-08
ATE514694T1 (de) 2011-07-15

Similar Documents

Publication Publication Date Title
IL190446A0 (en) 2-amino-7,8-dihydro-6h-pyrido[4,3-d]
IL182099A0 (en) Piperidinylamino-thieno[2,3-d] pyrimidine compounds
IL198250A0 (en) Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b
AP2008004486A0 (en) Pyrimidine derivatives
GB0525080D0 (en) Pyrimidine derivatives
GB0525083D0 (en) Pyrimidine derivatives
IL181433A0 (en) Pyrimidine derivatives
EP1878727A4 (en) 2-AMINOQUINAZOLINE DERIVATIVES
PL1963369T3 (pl) Antagoniści IL-21
IL181386A0 (en) Pyrimidine derivatives
GB0415364D0 (en) Pyrimidine derivatives
HK1104553A1 (en) Pyrimidine derivatives
ZA200805354B (en) Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives
GB0525081D0 (en) Pyrimidine derivatives
IL183140A0 (en) Substituted benzoquinolizine derivatives
GB2431338B (en) Cup
EP1971588A4 (en) TIGLIEN-3-one derivatives
ZA200803658B (en) 2-amino-7,8-dihydro-6H-pyrido[4,3-d] pyrimidin-5-ones
IL182739A0 (en) Acylatednonadepsipeptides used as lysobactin derivatives
IL181722A0 (en) 4-amino substituted-2-substituted
GB0415367D0 (en) Pyrimidine derivatives
GB0509066D0 (en) Shoulder rest
PL1693133T3 (pl) Uchwyt narzędziowy
HK1110079A1 (en) Imidazopyridine derivative
TWI340746B (en) Naphthyridin derivatives